"Patients on chemotherapy should not ignore symptoms like fatigue, thinking it's just related to the chemotherapy. The treating physician should be made aware of these symptoms, as this could lead to ...

BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascular outcomes. The ...

Please provide your email address to receive an email when new articles are posted on . A liberal vs. restrictive transfusion strategy yielded similar rates of death or MI at 30 days in patients with ...

Underuse of erythropoiesis-stimulating agents (ESA) and ESA hyporesponsiveness are 2 important reasons for red blood cell transfusion, according to a recent review. It is difficult to avoid the use of ...

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to ...

A more liberal transfusion strategy for patients with acute MI and anemia does not improve quality of life when compared with a more restrictive approach, according to an analysis of the MINT trial.

“Blood is a precious resource, and transfusion is costly, logistically cumbersome, and has side effects,” investigator P. Gabriel Steg, MD (Hôpital Bichat, Paris, France), told the media in a press ...

In patients with myocardial infarction (MI) and anemia, a "liberal" red blood cell (RBC) transfusion strategy did not significantly reduce the risk of recurrent MI or death within 30 days compared ...